Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.
Saved in:
| Title: | Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization. |
|---|---|
| Authors: | Konrath, Kylie M.1,2 (AUTHOR), Liaw, Kevin1 (AUTHOR), Tursi, Nicholas J.1,2 (AUTHOR), McCanna, Madison E.1 (AUTHOR), Warner, Bryce M.3,4,5 (AUTHOR), Gary, Ebony N.1 (AUTHOR), Zhu, Xizhou1 (AUTHOR), Livingston, Cory1 (AUTHOR), Monastra, Cara1 (AUTHOR), Frase, Drew1 (AUTHOR), Chokkalingam, Neethu1 (AUTHOR), Huynh, Alana1 (AUTHOR), Shupin, Nicholas1 (AUTHOR), Bayruns, Kelly1 (AUTHOR), Kriete, Sinja1 (AUTHOR), Kim, Amber1 (AUTHOR), Park, Joyce1 (AUTHOR), Vendramelli, Robert3 (AUTHOR), Truong, Thang3 (AUTHOR), Tierney, Kevin3 (AUTHOR) |
| Source: | PLoS Pathogens. 2/19/2026, Vol. 22 Issue 2, p1-27. 27p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15537366 |
|---|---|
| DOI: | 10.1371/journal.ppat.1013905 |